MARS Bioimaging Ltd spectral CT for biomedical imaging

MARS Bioimaging Ltd spectral CT for biomedical imaging Anthony Butler www. marsbioimaing. com

Overview Founded 2008: Spin out of University of Canterbury Exclusive licence for CERN Medipix 3 detector technology Own all IP relating spectral CT from the university Products: MARS scanners: Medipix 3 based micro. CT system MARS camera: Medipix 3 detector and readout for integration into 3 rd party CTs

Technology and its uses

Spectral CT is now possible Medipix All Resolution System Energy resolution Spatial resolution MARS spectral CT Temporal resolution Xray source Medipix Color detectors

Low GAG Cartilage Bone

MBI Products

MARS scanner micro. CT for small animal and pathology researcher

MARS Medipix 3 camera system for integration into 3 rd party systems Up to 8 Simultaneous energies 55µm or 110 µm pixel pitch resolution 1 to 6 Medipix chips (28 x 52 mm array) Silicon or Cd. Te/CZT Excellent energy resolution ( Charge sharing compensation ) Image of PCB taken with Medipix 3 Si-quad, 28 x 28 mm

MBI Company information

Market strategy Get MARS systems to key opinion leader’s labs Enable researchers using MARS tool to validate spectral CT Provide camera units for existing pre-clinical manufacturers to integrate into their systems Leverage pre-clinical adoption to find partner for human imaging

MARS project structure MARS is the technology MARS Bioimaging Ltd aka. “MBI” Commercial outlet for NZ’s R+D Research teams University of Canterbury University of Otago

MARS project structure MARS Bioimaging Ltd aka. “MBI” Commercial outlet for NZ’s R+D Shareholders University of Canterbury Individual scientist Private investors

MARS IP structure MARS Bioimaging Ltd All IP relating to spectral CT technology University of Canterbury Sub-contract for pre-clinical research University of Otago Exclusive license for small animal and human CT Medipix 3 Collaboration

MARS Funding structure Investment MARS Bioimaging Ltd University of Canterbury University of Otago Medipix 3 Collaboration

MARS Funding structure Sales Investment MARS Bioimaging Ltd University of Canterbury University of Otago Medipix 3 Collaboration

MARS Funding structure Sales Investment MARS Bioimaging Ltd Scholarship funding University of Canterbury University of Otago Contribution to Medipix 3 development Medipix 3 Collaboration

MARS Funding structure Sales Investment MARS Bioimaging Ltd Scholarship funding University of Canterbury University of Otago Contribution to Medipix 3 development Medipix 3 Collaboration NZ government funding

Why would a researcher do this?

Government instruction 80% of NZ government funding is aimed at economic return Key concept is international revenue Want a route to market early in an R+D program

Benefit to research Provides direction and focus Get the technology into users hands early Provides new funding routes

Personal Satisfaction – your research is used!!! New challenges

Personal Satisfaction – your research is used!!! New challenges Potential for financial gain… …. but I’m a radiologist!!

Summary MARS-CT make spectral CT possible Early adopters already purchasing www. marsbioimaging. com